AlloSource received a U.S. patent for its proprietary method to create ProChondrixCR, the company's fresh cryopreserved osteochondral allograft.
Here are three things to know:
1. The patent, titled "Enclosure for laser cutting of human tissue," includes AlloSource's process of producing a closed system that allows a laser beam to pass through and etch allograft tissue while maintaining a sterile barrier.
2. The method is designed to expedite processing, maximize tissue use and allow for the use of a specialized laser technology in a clean room setting.
3. ProChondrixCR is a cartilage restoration therapy. "Laser etching stimulates the cartilage regenerative system while the graft replaces the missing cartilage in superficial defects down to the bone level," said AlloSource Senior Medical Director Ross Wilkins, MD.